Impax Receives FDA Approval for Generic Version of DIABETA® (Glyburide) Tablets, USP, 1.25 mg, 2.5 mg, and 5 mg

By: via Benzinga
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has approved its generic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.